We also showed that HCC with S100P expression alone had 3- and 5-fold higher frequencies of vascular invasion (75%) and ETR (57%), than those observed for HCC with the β-catenin mutation and absence of S100P expression, which had the lowest frequency of vascular invasion (21%) and ETR (12%). The gene discussed is S100P; the disease is hepatocellular carcinoma.